CNS Pharmaceuticals, Inc. — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CNS Pharmaceuticals, Inc. (CNSP)
CIK: 0001729427
Period of Report: 2021-07-15

Reporting Person: Evans Carl Anthony (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-15	Option to purchase common stock	$1.80	A	32000	Acquired	2031-07-15	Common Stock (32000)	Direct

Footnotes

F1: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date hereof or the date of the 2022 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

F2: The stock options were issued in connection with the reporting person's Board of Director services to the Company.